Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:716-728
Published online before print February 9, 2006, doi: 10.1161/01.ATV.0000209518.58252.17
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/4/716    most recent
01.ATV.0000209518.58252.17v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Hinsbergh, V. W.M.
Right arrow Articles by Quax, P. H.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Hinsbergh, V. W.M.
Right arrow Articles by Quax, P. H.A.
Related Collections
Right arrow Angiogenesis
Right arrow Novel Mediators and Mechanisms in Angiogenesis and Vasculogenesis
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:716.)
© 2006 American Heart Association, Inc.


Brief Reviews

Pericellular Proteases in Angiogenesis and Vasculogenesis

Victor W.M. van Hinsbergh; Marten A. Engelse; Paul H.A. Quax

From the Laboratory for Physiology (V.W.M.H., M.A.E.), Institute for Cardiovascular Research, VU University Medical Center, Amsterdam; TNO Quality of Life (P.H.A.Q.), Gaubius Laboratory, Dept. Biomedical Research, Leiden, The Netherlands.

Correspondence to Victor W.M. van Hinsbergh, PhD, Laboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. E-mail v.vanhinsbergh{at}vumc.nl

Series Editor: Stephanie Dimmeler
ATVB In Focus Novel Mediators and Mechanisms in Angiogenesis and Vasculogenesis

Previous Brief Reviews in this Series:



•Ferguson JE III, Kelley RW, Patterson C. Mechanisms of endothelial differentiation in embryonic vasculogenesis. 2005;26:2246–2254.
•Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? 2006;26:257–266.

Pericellular proteases play an important role in angiogenesis and vasculogenesis. They comprise (membrane-type) matrix metalloproteinases [(MT-)MMPs], serine proteases, cysteine cathepsins, and membrane-bound aminopeptidases. Specific inhibitors regulate them. Major roles in initiating angiogenesis have been attributed to MT1-matrix metalloproteinase (MMP), MMP-2, and MMP-9. Whereas MT-MMPs are membrane-bound by nature, MMP-2 and MMP-9 can localize to the membrane by binding to {alpha}vß3-integrin and CD44, respectively. Proteases switch on neovascularization by activation, liberation, and modification of angiogenic growth factors and degradation of the endothelial and interstitial matrix. They also modify the properties of angiogenic growth factors and cytokines. Neovascularization requires cell migration, which depends on the assembly of protease–protein complexes at the migrating cell front. MT1-MMP and urokinase (u-PA) form multiprotein complexes in the lamellipodia and focal adhesions of migrating cells, facilitating proteolysis and sufficient support for endothelial cell migration and survival. Excessive proteolysis causes loss of endothelial cell-matrix interaction and impairs angiogenesis. MMP-9 and cathepsin L stimulate the recruitment and action of blood- or bone-marrow-derived accessory cells that enhance angiogenesis. Proteases also generate fragments of extracellular matrix and hemostasis factors that have anti-angiogenic properties. Understanding the complexity of protease activities in angiogenesis contributes to recognizing new targets for stimulation or inhibition of neovascularization in disease.

Pericellular proteases are involved in angiogenesis and vasculogenesis. They contribute to the degradation of the endothelial basal membrane, cell migration and invasion, and activation and liberation of angiogenic growth factors. They alter the properties of growth factors and cytokines by truncation, and generate protein fragments that have anti-angiogenic properties.


Key Words: endothelium • neovascularization • matrix metalloproteinases • MT-MMPs • cathepsins




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
A. Thulin, M. Ringvall, A. Dimberg, K. Karehed, T. Vaisanen, M.-R. Vaisanen, O. Hamad, J. Wang, R. Bjerkvig, B. Nilsson, et al.
Activated Platelets Provide a Functional Microenvironment for the Antiangiogenic Fragment of Histidine-Rich Glycoprotein
Mol. Cancer Res., November 1, 2009; 7(11): 1792 - 1802.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Linder
Invadosomes at a glance
J. Cell Sci., September 1, 2009; 122(17): 3009 - 3013.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P.-H. Huang, Y.-H. Chen, C.-H. Wang, J.-S. Chen, H.-Y. Tsai, F.-Y. Lin, W.-Y. Lo, T.-C. Wu, M. Sata, J.-W. Chen, et al.
Matrix Metalloproteinase-9 Is Essential for Ischemia-Induced Neovascularization by Modulating Bone Marrow-Derived Endothelial Progenitor Cells
Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1179 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
I. Laitinen, A. Saraste, E. Weidl, T. Poethko, A. W. Weber, S. G. Nekolla, P. Leppanen, S. Yla-Herttuala, G. Holzlwimmer, A. Walch, et al.
Evaluation of {alpha}v{beta}3 Integrin-Targeted Positron Emission Tomography Tracer 18F-Galacto-RGD for Imaging of Vascular Inflammation in Atherosclerotic Mice
Circ Cardiovasc Imaging, July 1, 2009; 2(4): 331 - 338.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-H. Chang, K. Kanasaki, V. Gocheva, G. Blum, J. Harper, M. A. Moses, S.-C. Shih, J. A. Nagy, J. Joyce, M. Bogyo, et al.
VEGF-A Induces Angiogenesis by Perturbing the Cathepsin-Cysteine Protease Inhibitor Balance in Venules, Causing Basement Membrane Degradation and Mother Vessel Formation
Cancer Res., May 15, 2009; 69(10): 4537 - 4544.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. D. Bass, M. R. Morgan, and M. J. Humphries
Syndecans Shed Their Reputation as Inert Molecules
Sci. Signal., March 31, 2009; 2(64): pe18 - pe18.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Plaisier, I. Dennert, E. Rost, P. Koolwijk, V.W.M. van Hinsbergh, and F.M. Helmerhorst
Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions
Hum. Reprod., January 1, 2009; 24(1): 185 - 197.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Waldeck, F. Hager, C. Holtke, C. Lanckohr, A. von Wallbrunn, G. Torsello, W. Heindel, G. Theilmeier, M. Schafers, and C. Bremer
Fluorescence Reflectance Imaging of Macrophage-Rich Atherosclerotic Plaques Using an {alpha}v{beta}3 Integrin-Targeted Fluorochrome
J. Nucl. Med., November 1, 2008; 49(11): 1845 - 1851.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Alfranca, J. M. Lopez-Oliva, L. Genis, D. Lopez-Maderuelo, I. Mirones, D. Salvado, A. J. Quesada, A. G. Arroyo, and J. M. Redondo
PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGF{beta}/Alk5 signaling pathway
Blood, August 15, 2008; 112(4): 1120 - 1128.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. D. Martin, K. J. Carter, S. R. Jean-Philippe, M. Chang, S. Mobashery, S. Thiolloy, C. C. Lynch, L. M. Matrisian, and B. Fingleton
Effect of Ablation or Inhibition of Stromal Matrix Metalloproteinase-9 on Lung Metastasis in a Breast Cancer Model Is Dependent on Genetic Background
Cancer Res., August 1, 2008; 68(15): 6251 - 6259.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Nyalendo, E. Beaulieu, H. Sartelet, M. Michaud, N. Fontaine, D. Gingras, and R. Beliveau
Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice
Carcinogenesis, August 1, 2008; 29(8): 1655 - 1664.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Arnold, E. Mira, S. Muneer, G. Korpanty, A. W. Beck, S. E. Holloway, S. Manes, and R. A. Brekken
Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC
Experimental Biology and Medicine, July 1, 2008; 233(7): 860 - 873.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. Mitra, M. Goto, J. S. Lee, D. Maldonado, J. M.G. Taylor, Q. Pan, T. E. Carey, C. R. Bradford, M. E. Prince, K. G. Cordell, et al.
Rap1GAP Promotes Invasion via Induction of Matrix Metalloproteinase 9 Secretion, Which Is Associated with Poor Survival in Low N-Stage Squamous Cell Carcinoma
Cancer Res., May 15, 2008; 68(10): 3959 - 3969.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. Koyama, H. Naruo, Y. Yoshitomi, S. Munesue, S. Kiyono, Y. Kusano, K. Hashimoto, T. Yokoi, H. Nakanishi, S. Shimizu, et al.
Matrix Metalloproteinase-9 Associated with Heparan Sulphate Chains of GPI-Anchored Cell Surface Proteoglycans Mediates Motility of Murine Colon Adenocarcinoma Cells
J. Biochem., May 1, 2008; 143(5): 581 - 592.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. W.M. van Hinsbergh and P. Koolwijk
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
Cardiovasc Res, May 1, 2008; 78(2): 203 - 212.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-S. Silvestre, Z. Mallat, A. Tedgui, and B. I. Levy
Post-ischaemic neovascularization and inflammation
Cardiovasc Res, May 1, 2008; 78(2): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Plaisier, P. Koolwijk, F. Willems, F. M. Helmerhorst, and V. W.M. van Hinsbergh
Pericellular-acting proteases in human first trimester decidua
Mol. Hum. Reprod., January 1, 2008; 14(1): 41 - 51.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Partridge, M. A. Madsen, V. C. Ardi, T. Papagiannakopoulos, T. A. Kupriyanova, J. P. Quigley, and E. I. Deryugina
Functional Analysis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Differentially Expressed by Variants of Human HT-1080 Fibrosarcoma Exhibiting High and Low Levels of Intravasation and Metastasis
J. Biol. Chem., December 7, 2007; 282(49): 35964 - 35977.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. H.C. Guimaraes, N. Laurens, E. M. Weijers, P. Koolwijk, V. W.M. van Hinsbergh, and D. C. Rijken
TAFI and Pancreatic Carboxypeptidase B Modulate In Vitro Capillary Tube Formation by Human Microvascular Endothelial Cells
Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2157 - 2162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Leali, E. Moroni, F. Bussolino, and M. Presta
Osteopontin Overexpression Inhibits in Vitro Re-endothelialization via Integrin Engagement
J. Biol. Chem., July 6, 2007; 282(27): 19676 - 19684.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
M. S. Agren and M. Werthen
The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds
International Journal of Lower Extremity Wounds, June 1, 2007; 6(2): 82 - 97.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer
Nonclassic Endogenous Novel Regulators of Angiogenesis
Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Nyalendo, M. Michaud, E. Beaulieu, C. Roghi, G. Murphy, D. Gingras, and R. Beliveau
Src-dependent Phosphorylation of Membrane Type I Matrix Metalloproteinase on Cytoplasmic Tyrosine 573: ROLE IN ENDOTHELIAL AND TUMOR CELL MIGRATION
J. Biol. Chem., May 25, 2007; 282(21): 15690 - 15699.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Cretu, J. M. Roth, M. Caunt, A. Akalu, D. Policarpio, S. Formenti, P. Gagne, L. Liebes, and P. C. Brooks
Disruption of Endothelial Cell Interactions with the Novel HU177 Cryptic Collagen Epitope Inhibits Angiogenesis
Clin. Cancer Res., May 15, 2007; 13(10): 3068 - 3078.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. W. Cheng, M. Kuzuya, K. Nakamura, K. Maeda, M. Tsuzuki, W. Kim, T. Sasaki, Z. Liu, N. Inoue, T. Kondo, et al.
Mechanisms Underlying the Impairment of Ischemia-Induced Neovascularization in Matrix Metalloproteinase 2-Deficient Mice
Circ. Res., March 30, 2007; 100(6): 904 - 913.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Ivanciu, R. D. Gerard, H. Tang, F. Lupu, and C. Lupu
Adenovirus-Mediated Expression of Tissue Factor Pathway Inhibitor-2 Inhibits Endothelial Cell Migration and Angiogenesis
Arterioscler Thromb Vasc Biol, February 1, 2007; 27(2): 310 - 316.
[Abstract] [Full Text] [PDF]